Clinical and Cost-effectiveness of Allium sativum oil versus Mineral Trioxide Aggregate in primary molars pulpotomy in a group of Egyptian children: A Randomised Clinical Pilot Study.

Document Type : Original Article

Authors

1 Pediatric dentistry and dental public health department, faculty of dentistry, Cairo University, Egypt.

2 Professor, Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Cairo University

3 Associate professor of pediatric dentistry and dental public health, faculty of dentistry,Cairo university

Abstract

Aim: To determine and compare the clinical and cost-effectiveness (CE) of Allium Sativum oil (ASO) versus Mineral trioxide aggregate (MTA) in primary molars pulpotomy in a group of Egyptian children. Methodology: This is a randomised clinical pilot study with two arms, parallel groups, and allocation blinded. Twenty-six children (n=52) participated in this clinical trial with maxillary and mandibular second primary molars indicated for vital pulpotomy and were randomly allocated into two equal groups. Group (I): pulpotomy using ASO, and Group (II): using MTA as pulpotomy agents. The follow-up period was one year, and the primary outcome was evaluating clinical effectiveness for both groups through the help of predetermined criteria during the follow-up period and according to the participant timeline. The secondary outcome was CE, measured using incremental CE ratio (ICER) and average CE ratio (ACER). Results: The relative risk of radiographic failure signs of the ASO group over the MTA group was (1.3) (95% CI 0.89:1.7) after 12 months. MTA had a higher (ACER) (67.00) than ASO (39.55). Conclusions: Allium Sativum oil is non-inferior to Mineral trioxide aggregate regarding clinical efficacy. ASO has a lower average cost-effectiveness ratio than MTA.

Keywords

Main Subjects

Advanced Dental Journal
Volume 6, Issue 4
October 2024
Pages 631-643

Files

Share

How to cite

Statistics